Effect of ranibizumab on retinopathy of prematurity: A meta-analysis
The primary objective of this study was to systematically evaluate the clinical efficacy of intravitreal ranibizumab injection in the treatment for retinopathy of prematurity (ROP) in infants. The MEDLINE (PubMed), Embase, China Biology Medicine disc, Cochrane Library, Web of Science, WanFang Data,...
Saved in:
Main Authors: | Zhibin Wang (Author), Zhaobo Zhang (Author), Yue Wang (Author), Yu Di (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis
by: Niza Alva, et al.
Published: (2023) -
Comparison of Single-Treatment Efficacy of Bevacizumab and Ranibizumab for Retinopathy of Prematurity
by: Fumio Takano, et al.
Published: (2024) -
Comparison of ranibizumab and conbercept treatment in type 1 prethreshold retinopathy of prematurity in zone II
by: Xiu-Mei Yang, et al.
Published: (2024) -
The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis
by: Jing Chen, et al.
Published: (2023) -
Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis
by: Wang LP, et al.
Published: (2018)